At a glance
ClinicalIndex Comparison RecordN/ACompleted· 268 enrolled
Drug / intervention
Lotrafilcon B multifocal contact lenses (new) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Visual Performance With a Multifocal High ADD Soft Contact Lens Design
In Brief
A clinical study evaluating Lotrafilcon B multifocal contact lenses (new) and Lotrafilcon B multifocal contact lenses for Presbyopia. Completed, enrolled 268 participants.
Detailed Summary
The purpose of this study is to evaluate the visual performance of a new multifocal High ADD contact lens compared to the currently-marketed AIR OPTIX® AQUA MULTIFOCAL (AOAMF) High ADD Contact Lens.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartApr 2014
First PostedApr 2014
Primary CompletionJul 2014
TodayJul 2026
First PostedApr 21, 2014
Enrollment StartApr 1, 2014
Primary CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 12.2 years ago
Interventions
Lotrafilcon B multifocal contact lenses (new)device
Lotrafilcon B multifocal contact lensesdevice